AN2 Therapeutics ANTX Peer Comparison

NASDAQ ANTX
$5.89 -0.06 (-1.01%)
At close: Sep 4, 2026 · 4:00 PM EDT
Peer Comparison

300 Comparable Companies

Industry Biotechnology

AN2 Therapeutics, Inc. (ANTX) is the 187th largest of 300 Biotechnology companies by market capitalisation, at 262.30 Mn, behind Surrozen, Inc./DE at 263.35 Mn. The table below compares all 300 on 8 financial metrics.

Download Data
# Ticker Company match industry_code industry_group industry_group_code Market Capitalization P/E P/S Enterprise Value
1 AMGN Amgen Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 236.46 Bn 0.00 Mn 6.21 222.47 Bn
2 GILD Gilead Sciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 187.36 Bn 0.00 Mn 6.15 184.18 Bn
3 VRTX Vertex Pharmaceuticals Inc / Ma primary H-02 Pharmaceuticals and Biotechnology HG-01 138.47 Bn 0.00 Mn 11.00 130.62 Bn
4 REGN Regeneron Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 85.18 Bn 0.00 Mn 5.48 77.19 Bn
5 ARGX Argenx Se primary H-02 Pharmaceuticals and Biotechnology HG-01 63.38 Bn 0.00 Mn 12.13 58.19 Bn
6 MRNA Moderna, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 58.09 Bn 0.00 Mn 26.07 52.95 Bn
7 ALNY Alnylam Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 35.57 Bn 0.00 Mn 7.40 32.27 Bn
8 BIIB Biogen Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 32.63 Bn 0.00 Mn 3.25 31.34 Bn
9 INSM INSMED Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 27.48 Bn 0.00 Mn 24.15 26.32 Bn
10 ROIV Roivant Sciences Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 25.18 Bn 0.00 Mn 2,305.26 25.18 Bn
11 BNTX BioNTech SE primary H-02 Pharmaceuticals and Biotechnology HG-01 25.06 Bn 0.00 Mn 8.10 11.41 Bn
12 ASND Ascendis Pharma A/S primary H-02 Pharmaceuticals and Biotechnology HG-01 16.39 Bn 0.00 Mn 13.42 15.45 Bn
13 MDGL Madrigal Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 15.79 Bn 0.00 Mn 12.30 14.96 Bn
14 BBIO BridgeBio Pharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 14.65 Bn 0.00 Mn 20.55 13.93 Bn
15 SMMT Summit Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 13.67 Bn — — 12.98 Bn
16 HALO Halozyme Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 12.92 Bn 0.00 Mn 7.77 12.69 Bn
17 BMRN Biomarin Pharmaceutical Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 12.88 Bn 0.00 Mn 3.78 12.01 Bn
18 ARWR Arrowhead Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 12.40 Bn 0.00 Mn 18.52 10.80 Bn
19 PRAX Praxis Precision Medicines, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 10.28 Bn 0.00 Mn — 9.52 Bn
20 APGE Apogee Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 10.18 Bn 0.00 Mn — 9.20 Bn
21 PTGX Protagonist Therapeutics, Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 9.61 Bn 0.00 Mn 34.07 9.61 Bn
22 IONS Ionis Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 9.60 Bn 0.00 Mn 10.98 7.55 Bn
23 PCVX Vaxcyte, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 8.83 Bn 0.00 Mn — 8.83 Bn
24 IBRX ImmunityBio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 8.51 Bn 0.00 Mn 51.33 8.15 Bn
25 IMVT Immunovant, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 8.07 Bn 0.00 Mn — 8.07 Bn
26 ABVX Abivax S.A. primary H-02 Pharmaceuticals and Biotechnology HG-01 7.99 Bn 0.00 Mn — 7.99 Bn
27 TGTX Tg Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 7.97 Bn 0.00 Mn 9.97 7.29 Bn
28 SYRE Spyre Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 7.53 Bn 0.00 Mn — 7.53 Bn
29 SRRK Scholar Rock Holding Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 7.24 Bn 0.00 Mn — 7.24 Bn
30 RYTM Rhythm Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 7.02 Bn 0.00 Mn 29.27 6.69 Bn
31 BLRX BioLineRx Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 6.64 Bn 0.00 Mn 4,772.92 6.64 Bn
32 CGON CG Oncology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 6.60 Bn 0.00 Mn 1,060.37 6.60 Bn
33 MIRM Mirum Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 6.40 Bn 0.00 Mn 10.35 5.96 Bn
34 KNSA Kiniksa Pharmaceuticals International, plc primary H-02 Pharmaceuticals and Biotechnology HG-01 6.05 Bn 0.00 Mn 7.20 5.53 Bn
35 XENE Xenon Pharmaceuticals Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.96 Bn 0.00 Mn — 5.96 Bn
36 COGT Cogent Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.94 Bn 0.00 Mn — 5.94 Bn
37 DBVT DBV Technologies S.A. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.88 Bn 0.00 Mn 1,170.87 5.70 Bn
38 ORKA Oruka Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.85 Bn — — 4.12 Bn
39 PTCT Ptc Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.78 Bn 0.00 Mn 5.73 3.55 Bn
40 LGND Ligand Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 5.76 Bn 0.00 Mn 19.84 4.41 Bn
41 GRFS Grifols SA primary H-02 Pharmaceuticals and Biotechnology HG-01 5.31 Bn 0.00 Mn 0.32 4.15 Bn
42 CELC Celcuity Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.25 Bn 0.00 Mn — 5.25 Bn
43 ERAS Erasca, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.04 Bn 0.00 Mn — 5.04 Bn
44 RADX Radiopharm Theranostics Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 4.33 Bn 0.00 Mn 20,980.03 4.33 Bn
45 DNLI Denali Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 4.18 Bn 0.00 Mn 1,161.10 4.18 Bn
46 DNTH Dianthus Therapeutics, Inc. /DE/ primary H-02 Pharmaceuticals and Biotechnology HG-01 4.09 Bn — — 3.69 Bn
47 VKTX Viking Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 4.06 Bn 0.00 Mn — 4.06 Bn
48 TLX Telix Pharmaceuticals Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 4.03 Bn — — 3.74 Bn
49 DYN Dyne Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 4.02 Bn 0.00 Mn — 4.02 Bn
50 RLAY Relay Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.87 Bn 0.00 Mn 373.95 3.87 Bn
51 AMLX Amylyx Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.79 Bn 0.00 Mn — 3.79 Bn
52 RCUS Arcus Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.74 Bn 0.00 Mn 31.96 3.04 Bn
53 IDYA IDEAYA Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.68 Bn 0.00 Mn 15.73 2.85 Bn
54 ABCL AbCellera Biologics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.49 Bn 0.00 Mn 52.71 3.49 Bn
55 TNGX Tango Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.37 Bn 0.00 Mn 62.56 2.35 Bn
56 ARQT Arcutis Biotherapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.12 Bn 0.00 Mn 6.73 2.88 Bn
57 CLDX Celldex Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.10 Bn 0.00 Mn 19,590.55 3.10 Bn
58 IRON Disc Medicine, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.06 Bn 0.00 Mn — 3.06 Bn
59 IMNM Immunome Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.03 Bn 0.00 Mn 593.06 2.51 Bn
60 MBX MBX Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.97 Bn 0.00 Mn — 2.97 Bn
61 ZLAB Zai Lab Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 2.94 Bn 0.00 Mn 6.53 2.23 Bn
62 NRIX Nurix Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.90 Bn 0.00 Mn 78.89 2.46 Bn
63 SLS SELLAS Life Sciences Group, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.62 Bn 0.00 Mn — 2.62 Bn
64 VERA Vera Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.58 Bn 0.00 Mn — 2.58 Bn
65 BCRX Biocryst Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 2.54 Bn 0.00 Mn 4.75 2.19 Bn
66 NKTR Nektar Therapeutics primary H-02 Pharmaceuticals and Biotechnology HG-01 2.45 Bn 0.00 Mn 44.90 1.77 Bn
67 HCM HUTCHMED (China) Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 2.43 Bn 0.00 Mn 3.41 2.43 Bn
68 VRDN Viridian Therapeutics, Inc.\DE primary H-02 Pharmaceuticals and Biotechnology HG-01 2.42 Bn 0.00 Mn 33.96 2.42 Bn
69 OCUL Ocular Therapeutix, Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 2.40 Bn 0.00 Mn 46.07 2.40 Bn
70 BHVN Biohaven Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.37 Bn 0.00 Mn — 2.10 Bn
71 XTLB Xtl Biopharmaceuticals Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 2.27 Bn 0.00 Mn — 2.27 Bn
72 URGN UroGen Pharma Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.23 Bn 0.00 Mn 11.79 2.12 Bn
73 KOD Kodiak Sciences Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.21 Bn 0.00 Mn — 2.21 Bn
74 ADMA Adma Biologics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.19 Bn 0.00 Mn 4.28 2.06 Bn
75 GMAB Genmab A/S primary H-02 Pharmaceuticals and Biotechnology HG-01 2.17 Bn 0.00 Mn 0.34 0.67 Bn
76 RAPP Rapport Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.17 Bn 0.00 Mn 108.62 2.17 Bn
77 ZYME Zymeworks Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.13 Bn 0.00 Mn 57.49 1.86 Bn
78 PHVS Pharvaris N.V. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.10 Bn 0.00 Mn — 1.73 Bn
79 ZBIO Zenas BioPharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.09 Bn 0.00 Mn 2,085.86 2.09 Bn
80 XNCR Xencor Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 2.02 Bn 0.00 Mn 19.28 1.65 Bn
81 AGIO Agios Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.97 Bn 0.00 Mn 20.05 1.97 Bn
82 STOK Stoke Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.96 Bn 0.00 Mn 71.02 1.67 Bn
83 TYRA Tyra Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.94 Bn 0.00 Mn — 1.94 Bn
84 RXRX Recursion Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.93 Bn 0.00 Mn 35.26 1.38 Bn
85 VIR Vir Biotechnology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.92 Bn 0.00 Mn 6.32 1.92 Bn
86 INBX Inhibrx Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.91 Bn 0.00 Mn 1,465.41 1.91 Bn
87 LKFT Lakefront Biotherapeutics NV primary H-02 Pharmaceuticals and Biotechnology HG-01 1.88 Bn 0.00 Mn 1.63 1.88 Bn
88 IMCR Immunocore Holdings plc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.85 Bn 0.00 Mn 4.28 0.97 Bn
89 DMRA Damora Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.83 Bn 0.00 Mn — 1.29 Bn
90 SNDX Syndax Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.83 Bn 0.00 Mn 7.25 1.28 Bn
91 CMPS COMPASS Pathways plc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.79 Bn 0.00 Mn — 1.79 Bn
92 SCNI Scinai Immunotherapeutics Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.77 Bn 0.00 Mn 1,025.82 1.76 Bn
93 GHRS GH Research PLC primary H-02 Pharmaceuticals and Biotechnology HG-01 1.72 Bn 0.00 Mn — 1.36 Bn
94 NVAX Novavax Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.68 Bn 0.00 Mn 4.06 0.96 Bn
95 SEPN Septerna, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.66 Bn 0.00 Mn 16.77 1.66 Bn
96 ANAB Anaptysbio, Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.62 Bn 0.00 Mn 8.14 1.34 Bn
97 ATAI AtaiBeckley Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.61 Bn 0.00 Mn 530.56 1.61 Bn
98 FBRX Forte Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.58 Bn 0.00 Mn — 1.23 Bn
99 BCAX Bicara Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.57 Bn 0.00 Mn — 1.57 Bn
100 AAPG Ascentage Pharma Group International primary H-02 Pharmaceuticals and Biotechnology HG-01 1.57 Bn 0.00 Mn 20.12 1.29 Bn
101 RARE Ultragenyx Pharmaceutical Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.56 Bn 0.00 Mn 2.18 1.27 Bn
102 MAZE Maze Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.55 Bn 0.00 Mn 77.46 1.55 Bn
103 ANRO Alto Neuroscience, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.52 Bn 0.00 Mn — 1.52 Bn
104 AVBP ArriVent BioPharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.48 Bn 0.00 Mn — 1.48 Bn
105 REPL Replimune Group, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.46 Bn 0.00 Mn — 1.46 Bn
106 ALMS Alumis Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.42 Bn 0.00 Mn 170.77 0.92 Bn
107 GLUE Monte Rosa Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.40 Bn 0.00 Mn 48.89 0.77 Bn
108 ABSI Absci Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 1.39 Bn 0.00 Mn 889.25 1.19 Bn
109 ORIC Oric Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.38 Bn 0.00 Mn — 1.38 Bn
110 OMER Omeros Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 1.38 Bn 0.00 Mn 35.80 1.38 Bn
111 CGEM Cullinan Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.37 Bn 0.00 Mn — 1.37 Bn
112 SVRA Savara Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.36 Bn 0.00 Mn — 1.36 Bn
113 VOR Vor Biopharma Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.36 Bn 0.00 Mn — 1.36 Bn
114 CRVS Corvus Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.33 Bn 0.00 Mn — 1.12 Bn
115 JANX Janux Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.27 Bn 0.00 Mn 52.84 1.27 Bn
116 MNKD Mannkind Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 1.26 Bn 0.00 Mn 3.21 1.15 Bn
117 JBIO Jade Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.21 Bn 0.00 Mn — 1.21 Bn
118 CLYM Climb Bio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.18 Bn 0.00 Mn — 1.18 Bn
119 MLTX MoonLake Immunotherapeutics primary H-02 Pharmaceuticals and Biotechnology HG-01 1.11 Bn 0.00 Mn — 0.57 Bn
120 OKYO OKYO Pharma Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 1.05 Bn 0.00 Mn — 1.05 Bn
121 GERN Geron Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 1.05 Bn 0.00 Mn 4.32 0.75 Bn
122 ABUS Arbutus Biopharma Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 1.02 Bn 0.00 Mn 5.61 0.93 Bn
123 MNPR Monopar Therapeutics primary H-02 Pharmaceuticals and Biotechnology HG-01 1.01 Bn 0.00 Mn — 0.95 Bn
124 WVE Wave Life Sciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.99 Bn 0.00 Mn 15.21 0.63 Bn
125 ANNX Annexon, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.98 Bn 0.00 Mn — 0.98 Bn
126 ARDX Ardelyx, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.93 Bn 0.00 Mn 2.07 0.65 Bn
127 RIGL Rigel Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.90 Bn 0.00 Mn 3.26 0.81 Bn
128 STTK Shattuck Labs, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.89 Bn 0.00 Mn 885.09 0.89 Bn
129 TBPH Theravance Biopharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.88 Bn 0.00 Mn 8.46 0.50 Bn
130 ACRS Aclaris Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.88 Bn 0.00 Mn 107.41 0.88 Bn
131 AVTX Avalo Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.84 Bn 0.00 Mn — 0.84 Bn
132 CTMX CytomX Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.81 Bn 0.00 Mn 44.44 0.48 Bn
133 PHAR Pharming Group N.V. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.79 Bn 0.00 Mn 2.39 0.64 Bn
134 ZURA Zura Bio Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.79 Bn 0.00 Mn — 0.79 Bn
135 BBOT BridgeBio Oncology Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.72 Bn 0.00 Mn — 0.50 Bn
136 AURA Aura Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.72 Bn 0.00 Mn — 0.65 Bn
137 IRWD Ironwood Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.70 Bn 0.00 Mn 1.80 0.62 Bn
138 SLN Silence Therapeutics plc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.69 Bn 0.00 Mn 1,122.93 0.62 Bn
139 ASMB Assembly Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.69 Bn 0.00 Mn 9.21 0.37 Bn
140 ALT Altimmune, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.64 Bn 0.00 Mn — 0.64 Bn
141 CBIO Crescent Biopharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.64 Bn 0.00 Mn 612.11 0.46 Bn
142 OCS Oculis Holding AG primary H-02 Pharmaceuticals and Biotechnology HG-01 0.63 Bn -0.36 Mn — 0.35 Bn
143 CTNM Contineum Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.63 Bn 0.00 Mn — 0.63 Bn
144 ARVN Arvinas, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.61 Bn 0.00 Mn 1.93 0.04 Bn
145 TECX Tectonic Therapeutic, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.59 Bn 0.00 Mn — 0.59 Bn
146 SGMT Sagimet Biosciences Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.58 Bn 0.00 Mn — 0.58 Bn
147 VALN Valneva SE primary H-02 Pharmaceuticals and Biotechnology HG-01 0.58 Bn 551.06 Mn 3.47 0.44 Bn
148 OABI OmniAb, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.55 Bn 0.00 Mn 14.37 0.50 Bn
149 IMUX Immunic, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.55 Bn 0.00 Mn — 0.55 Bn
150 PRLD Prelude Therapeutics Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.54 Bn 0.00 Mn 24.04 0.26 Bn
151 PRTA Prothena Corp Public Ltd Co primary H-02 Pharmaceuticals and Biotechnology HG-01 0.51 Bn 0.00 Mn 9.41 0.22 Bn
152 ANL Adlai Nortye Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.50 Bn 0.00 Mn 78.36 0.27 Bn
153 RLMD Relmada Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.50 Bn 0.00 Mn — 0.50 Bn
154 CCCC C4 Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.49 Bn 0.00 Mn 14.06 0.24 Bn
155 KMDA Kamada Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.49 Bn 0.00 Mn 2.56 0.42 Bn
156 PBYI Puma Biotechnology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.49 Bn 0.00 Mn 2.11 0.39 Bn
157 RZLT Rezolute, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.48 Bn 0.00 Mn — 0.48 Bn
158 NEUP Neuphoria Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn 0.00 Mn — 0.45 Bn
159 AVIR Atea Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn 0.00 Mn — 0.47 Bn
160 ARCT Arcturus Therapeutics Holdings Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.45 Bn 0.00 Mn 15.31 0.26 Bn
161 DRUG Bright Minds Biosciences Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.45 Bn 0.00 Mn — 0.23 Bn
162 CMPX Compass Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.45 Bn 0.00 Mn — 0.45 Bn
163 EVMN Evommune, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.45 Bn 0.00 Mn 44.52 0.24 Bn
164 BIOA BioAge Labs, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.43 Bn 0.00 Mn 41.79 0.43 Bn
165 ENTA Enanta Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.41 Bn 0.00 Mn 6.27 0.22 Bn
166 EYPT EyePoint, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.40 Bn 0.00 Mn 142.89 0.22 Bn
167 LRMR Larimar Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.40 Bn 0.00 Mn — 0.24 Bn
168 CATX Perspective Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.38 Bn 0.00 Mn — 0.38 Bn
169 WHWK Whitehawk Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.38 Bn 0.00 Mn — 0.38 Bn
170 FHTX Foghorn Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.35 Bn 0.00 Mn 9.47 0.28 Bn
171 ELDN Eledon Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.34 Bn 0.00 Mn — 0.34 Bn
172 AGEN Agenus Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.34 Bn 0.00 Mn 2.58 0.34 Bn
173 STRO Sutro Biopharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.33 Bn 0.00 Mn 3.72 0.17 Bn
174 EPRX Eupraxia Pharmaceuticals Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.33 Bn 0.00 Mn — 0.33 Bn
175 UPB Upstream Bio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.33 Bn 0.00 Mn 103.85 0.33 Bn
176 GALT Galectin Therapeutics Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.30 Bn 0.00 Mn — 0.30 Bn
177 BCYC Bicycle Therapeutics Plc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.30 Bn 0.00 Mn 4.90 0.30 Bn
178 TRDA Entrada Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.30 Bn 0.00 Mn 63.39 0.30 Bn
179 SABS SAB Biotherapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.30 Bn 0.00 Mn — 0.30 Bn
180 ACIU AC Immune SA primary H-02 Pharmaceuticals and Biotechnology HG-01 0.29 Bn 0.00 Mn 12.87 0.29 Bn
181 MGNX Macrogenics Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn 0.00 Mn 1.70 0.17 Bn
182 ALXO Alx Oncology Holdings Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.27 Bn 0.00 Mn — 0.27 Bn
183 ALEC Alector, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.27 Bn 0.00 Mn 19.66 0.10 Bn
184 AVXL Anavex Life Sciences Corp. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.27 Bn 0.00 Mn — 0.15 Bn
185 IVVD Invivyd, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn 0.00 Mn 4.70 0.10 Bn
186 SRZN Surrozen, Inc./DE primary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn 0.00 Mn 22.88 0.26 Bn
187 ANTX AN2 Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn 0.00 Mn — 0.26 Bn
188 CAMP Camp4 Therapeutics Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn 0.00 Mn 61.69 0.26 Bn
189 CYDY CytoDyn Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn 0.00 Mn — 0.26 Bn
190 FIXX Q32 Bio Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn 0.00 Mn — 0.15 Bn
191 PYXS Pyxis Oncology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn 0.00 Mn 18.03 0.22 Bn
192 EQ Equillium, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn 0.00 Mn — 0.25 Bn
193 NMRA Neumora Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.24 Bn 0.00 Mn — 0.24 Bn
194 CGEN Compugen Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.24 Bn 0.00 Mn 3.28 0.16 Bn
195 YDES YD Bio Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.24 Bn 0.00 Mn 287.04 0.23 Bn
196 GLSI Greenwich LifeSciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.23 Bn 0.00 Mn — 0.23 Bn
197 ABOS Acumen Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.23 Bn 0.00 Mn — 0.23 Bn
198 FTH Faeth Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.23 Bn 0.00 Mn — 0.23 Bn
199 KROS Keros Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn 0.00 Mn 6.82 -0.03 Bn
200 CHRS Coherus Oncology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn 0.00 Mn 4.35 0.12 Bn
201 PRQR ProQR Therapeutics N.V. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn 0.00 Mn 10.17 0.08 Bn
202 PEPG PepGen Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn 0.00 Mn — 0.22 Bn
203 KRRO Korro Bio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn 0.00 Mn 90.64 0.10 Bn
204 PLX Protalix BioTherapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn 0.00 Mn 2.64 0.17 Bn
205 ARMP Armata Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn 0.00 Mn — 0.19 Bn
206 ADAG Adagene Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn 0.00 Mn 32.66 0.21 Bn
207 ADCT ADC Therapeutics SA primary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn 0.00 Mn 2.77 -0.01 Bn
208 ORMP Oramed Pharmaceuticals Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn 0.00 Mn — 0.21 Bn
209 NBP NovaBridge Biosciences primary H-02 Pharmaceuticals and Biotechnology HG-01 0.20 Bn 0.00 Mn — 0.20 Bn
210 IPHA Innate Pharma SA primary H-02 Pharmaceuticals and Biotechnology HG-01 0.19 Bn 0.00 Mn 60.95 0.19 Bn
211 QNCX Quince Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.18 Bn 0.00 Mn — 0.18 Bn
212 OKUR OnKure Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.18 Bn 0.00 Mn — 0.00 Bn
213 XLO Xilio Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.18 Bn 0.00 Mn 2.75 0.04 Bn
214 CUE Cue Biopharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.17 Bn 0.00 Mn 7.74 0.16 Bn
215 NGEN Nervgen Pharma Corp. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.17 Bn 0.00 Mn — 0.17 Bn
216 MIST Milestone Pharmaceuticals Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.17 Bn — — -0.01 Bn
217 RANI Rani Therapeutics Holdings, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.16 Bn 0.00 Mn 33.54 0.16 Bn
218 MOLN Molecular Partners Ag primary H-02 Pharmaceuticals and Biotechnology HG-01 0.16 Bn 0.00 Mn 28.43 0.16 Bn
219 ENTX Entera Bio Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.15 Bn 0.00 Mn — 0.14 Bn
220 MDWD MediWound Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.15 Bn 0.00 Mn 12.79 0.12 Bn
221 IFRX InflaRx N.V. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.15 Bn 0.00 Mn 1,890.67 -0.04 Bn
222 SPRB Spruce Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn 0.00 Mn — 0.14 Bn
223 UNCY Unicycive Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn 0.00 Mn — 0.14 Bn
224 CRBP Corbus Pharmaceuticals Holdings, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn — — -0.03 Bn
225 HURA TuHURA Biosciences, Inc./NV primary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn 0.00 Mn — 0.14 Bn
226 IBIO iBio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn 0.00 Mn 1,368.39 0.14 Bn
227 RFL Rafael Holdings, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.13 Bn 0.00 Mn 135.92 0.13 Bn
228 MSLE Satellos Bioscience Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.13 Bn 0.00 Mn — 0.13 Bn
229 NRXP NRX Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.13 Bn 0.00 Mn 38.18 0.10 Bn
230 BDTX Black Diamond Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.12 Bn 0.00 Mn — 0.01 Bn
231 TLSA Tiziana Life Sciences Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.12 Bn 0.00 Mn — 0.12 Bn
232 PMN ProMIS Neurosciences Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.12 Bn 0.00 Mn — 0.06 Bn
233 INO Inovio Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.12 Bn 0.00 Mn — 0.12 Bn
234 CNTB Connect Biopharma Holdings Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.12 Bn 0.00 Mn 38.97 0.12 Bn
235 COYA Coya Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.11 Bn 0.00 Mn 13.84 0.07 Bn
236 GNLX GENELUX Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 0.11 Bn 0.00 Mn — 0.11 Bn
237 ONCY Oncolytics Biotech Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.10 Bn 0.00 Mn — 0.10 Bn
238 PLYX Polaryx Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.10 Bn 0.00 Mn — 0.09 Bn
239 RLYB Rallybio Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 0.10 Bn 0.00 Mn 149.14 0.10 Bn
240 KLRS Kalaris Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn 0.00 Mn — 0.09 Bn
241 OTLK Outlook Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn 0.00 Mn — 0.08 Bn
242 CTOR Citius Oncology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn 0.00 Mn 55.22 0.09 Bn
243 KZIA Kazia Therapeutics Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn — — 0.09 Bn
244 ACRV Acrivon Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn 0.00 Mn — 0.09 Bn
245 ALDX Aldeyra Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn 0.00 Mn — 0.09 Bn
246 PYPD PolyPid Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn 0.00 Mn — 0.08 Bn
247 RVRC Revium Rx. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn 0.00 Mn — 0.09 Bn
248 FBIO Fortress Biotech, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn 0.00 Mn 1.26 -0.11 Bn
249 MAIA MAIA Biotechnology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn 0.00 Mn — 0.05 Bn
250 ATHE Alterity Therapeutics Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn 0.00 Mn — 0.05 Bn
251 DWTX Dogwood Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn 0.00 Mn — 0.08 Bn
252 INDP Indaptus Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn 0.00 Mn — 0.07 Bn
253 GANX Gain Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn 0.00 Mn — 0.08 Bn
254 CRDF Cardiff Oncology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.07 Bn 0.00 Mn 126.21 0.07 Bn
255 SPRO Spero Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.07 Bn 0.00 Mn 1.50 0.02 Bn
256 TELO Telomir Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.07 Bn 0.00 Mn — 0.07 Bn
257 XBIT XBiotech Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.07 Bn 0.00 Mn — 0.07 Bn
258 HRTX Heron Therapeutics, Inc. /De/ primary H-02 Pharmaceuticals and Biotechnology HG-01 0.07 Bn 0.00 Mn 0.43 0.02 Bn
259 ALGS Aligos Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.06 Bn 0.00 Mn 17.17 0.03 Bn
260 SCYX Scynexis Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.06 Bn 0.00 Mn 3.26 -0.05 Bn
261 RNTX Rein Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.06 Bn 0.00 Mn — 0.06 Bn
262 IBO Impact Biomedical Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.06 Bn 0.00 Mn 1,613.93 0.06 Bn
263 MCRB Seres Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn 0.00 Mn 29.12 0.05 Bn
264 IMMP IMMUTEP Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn 0.00 Mn 5.23 0.00 Bn
265 NMAD Nomad Power Solutions, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn 0.00 Mn — 0.05 Bn
266 TIL Instil Bio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn 0.00 Mn — 0.05 Bn
267 PTN Palatin Technologies Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn 0.00 Mn 3.95 0.05 Bn
268 ATYR aTYR PHARMA INC primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn 0.00 Mn 294.15 -0.01 Bn
269 ELTX Elicio Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn 0.00 Mn — 0.02 Bn
270 HOWL Werewolf Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn 0.00 Mn 2.21 0.05 Bn
271 SER Serina Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn 0.00 Mn 341.56 0.02 Bn
272 EDSA Edesa Biotech, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn 0.00 Mn — 0.04 Bn
273 NXTC NextCure, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn 0.00 Mn — 0.04 Bn
274 IMA ImageneBio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn — — -0.09 Bn
275 MREO Mereo BioPharma Group plc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn 0.00 Mn 83.67 0.04 Bn
276 LITS Lite Strategy, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn 0.00 Mn — 0.03 Bn
277 APLM Apollomics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn 0.00 Mn 4.72 0.04 Bn
278 FLNA Filana Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn 0.00 Mn — 0.04 Bn
279 KYNB Kyntra Bio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.00 Mn 4.60 0.03 Bn
280 CNTX Context Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.00 Mn — 0.03 Bn
281 KAPA Kairos Pharma, LTD. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.00 Mn 0.35 0.03 Bn
282 BHST Bioharvest Sciences Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.00 Mn 0.93 0.02 Bn
283 ADIL Adial Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.00 Mn — 0.03 Bn
284 ATNM Actinium Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.00 Mn 0.92 0.03 Bn
285 BETRF BetterLife Pharma Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.00 Mn — 0.03 Bn
286 BRNS Barinthus Biotherapeutics plc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.00 Mn — 0.03 Bn
287 IGC IGC Pharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.00 Mn 93.50 0.03 Bn
288 CLRB Cellectar Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.00 Mn — 0.03 Bn
289 RAPH Raphael Pharmaceutical Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.00 Mn — 0.03 Bn
290 TAOX TAO Synergies Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.00 Mn 36.46 0.03 Bn
291 VRXA Veraxa Biotech AG - Post de-SPAC primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.00 Mn 755.61 0.02 Bn
292 ABVC Abvc Biopharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn 0.00 Mn — 0.02 Bn
293 NNVC Nanoviricides, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn 0.00 Mn — 0.02 Bn
294 LTRN Lantern Pharma Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn 0.00 Mn — 0.02 Bn
295 GRDX GridAI Technologies Corp. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn 0.00 Mn 239.09 0.02 Bn
296 EVAX Evaxion A/S primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn 0.00 Mn 2.68 0.02 Bn
297 JSPR Jasper Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn 0.00 Mn — 0.02 Bn
298 CNSY Cerenome, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn 0.00 Mn 4.55 0.01 Bn
299 DYAI Dyadic International Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn 0.00 Mn 4.97 0.02 Bn
300 KTTA Pasithea Therapeutics Corp. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn 0.00 Mn — 0.02 Bn